FDA Import Refusal SCS-4626991-7/11/1 — Miralax Merck

Miralax Merck — FEI 3010789625

The FDA refused shipment SCS-4626991-7/11/1 from Miralax Merck (United States) on May 15, 2019. The refused product falls under Drugs and Biologics — LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II). Cited charge: 75

Refusal details

Date
May 15, 2019
Country
United States
Product Category
Drugs and Biologics
Product Code
62OCA41 LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.